Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-004-2 | CAS number: 102-08-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Basic toxicokinetics
Administrative data
- Endpoint:
- basic toxicokinetics in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- publication
- Title:
- Diphenylthiourea, a common rubber chemical, is bioactivated to potent skin sensitizers.
- Author:
- Samuelsson K., Bergström MA., Jonsson CA, Westman G., and Karlberg AT.
- Year:
- 2 011
- Bibliographic source:
- Chem.Res.Toxicol.,24: 35-44.
Materials and methods
- Objective of study:
- metabolism
Test guideline
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- The aim of this study was to investigate if DPTU is a prohapten that can be activated by skin metabolism. This metabolic activation and covalent binding of 14C-labeled DPTU to proteins were tested using a skinlike cytochrome P450 cocktail containing the five most abundant P450s found in human skin (CYP1A1, 1B1, 2B6, 2E1 and 3A5) and human liver microsomes.
- GLP compliance:
- not specified
Test material
- Reference substance name:
- 1,3-diphenyl-2-thiourea
- EC Number:
- 203-004-2
- EC Name:
- 1,3-diphenyl-2-thiourea
- Cas Number:
- 102-08-9
- Molecular formula:
- C13H12N2S
- IUPAC Name:
- 1,3-diphenyl-2-thiourea
- Details on test material:
- no data
Constituent 1
- Specific details on test material used for the study:
- 14C-DPTU was synthesized by Isotope Chemistry at AstraZeneca R&D Mölndal (Moölndal, Sweden).
- Radiolabelling:
- yes
- Remarks:
- 14C-DPTU
Test animals
- Species:
- other: the skinlike P450 cocktail or human liver microsomes
Administration / exposure
- Route of administration:
- other: in vitro study
- Details on exposure:
- A mixture of 14C6-DPTU and unlabeled DPTU with a specific activity of 4.51 kBq/nmol was used for the microsomal incubations.
- Duration and frequency of treatment / exposure:
- 60 minutes
- Details on study design:
- The metabolism of 14C6-DPTU was assessed, and metabolites were detected after incubations with the skinlike P450 cocktail or human liver microsomes. The metabolites and trapped adducts were separated using reversed-phase HPLC and online RAD for quantification. MS/MS was used for structure elucidation.
Results and discussion
Metabolite characterisation studies
- Metabolites identified:
- yes
- Details on metabolites:
- The total conversion of DPTU after 60 min of incubation in human liver microsomes and the P450 cocktail was 29 and 12%, respectively. A loss of approximately 10% of parent was observed in the control experiments without NADPH and is considered to be due to decomposition of DPTU. This was confirmed in an additional control experiment run in the absence of metabolizing enzymes.
In total, six metabolites were detected in the human liver microsome incubations without trapping agents. Four of the metabolites were detected by MS and are denoted Ml-M4. In the P450 cocktail incubations, M1-M4 were detected, however, the nonidentified peaks from the human liver microsome incubations were not seen (Figure 2A). Amounts of metabolites formed and masses of metabolites are presented in Table 3. M1, a monooxygenated metabolite, was the major metabolite formed in incubations with both the P450 cocktail and the human liver microsomes. The minor metabolites M2-M4 were formed via monooxygenation (M2), desulfuration (M4), and combined oxygenation and desulfuration (M3).
The m/z given for the compounds is the unlabeled MH+. The MS/MS spectrum of DPTU (MH+ at m/z 229) contains product ions at m/z 195, 136, and 94. Proposed structures of the DPTU product ions are shown in the Supporting Information. M1 and M2 have pseudomolecular ions of m/z 245 corresponding to a net mass gain of +16 Da and are thus monooxygenated metabolites. Both M1 and M2 produced product ions at m/z 227, which indicates that both compounds lose the mass of one water molecule upon fragmentation of the parent at m/z 245. Hydroxylation on aromatic rings is a common metabolic pathway, but loss of water is unlikely to occur for phenols when subjected to collision-induced dissociation. Thus, on the basis of MS/MS interpretation, M1 and M2 are postulated to be the sulfenic acid (S-OH) and hydroxylamine (N-OH) of DPTU, respectively. S- and N-oxidations are catalyzed both by microsomal P450 and FMO (25). S-oxidation produces sulfenic (S-OH), sulfinic(SO2H), and sulfonic acids (SO3H). Thiourea sulfoxides are unstable and difficult to isolate and identify. For this reason, only the sulfenic acid of DPTU (M1) was identified in the metabolic mixture. Using a synthetic standard, metabolite M3 at m/z 213 was identified as diphenyl urea (DPU). M3 produced the same MS/MS spectrum and had the same retention time as the reference compound DPU (data not shown). Metabolite M4 was the most nonpolar metabolite identified. This compound was found in relatively low amounts and only in incubates without trapping agents. The protonated molecular ion had a m/z of 197 and is proposed to be diphenyl formamidine. Its MS/MS product ions at m/z 104 and 94 correspond to C2H6N and protonated aniline.
Applicant's summary and conclusion
- Conclusions:
- DPTU was mainly metabolically activated to reactive sulfoxides resulting in desulfurated adducts in both enzymatic systems used. Also, phenylisothiocyanate and phenylisocyanate were found to be metabolites of DPTU.
- Executive summary:
Diphenylthiourea (DPTU) is a known skin sensitizer commonly used as a vulcanization accelerator in the production of synthetic rubber, for example, neoprene. The versatile usage of neoprene is due to the multifaceted properties of the material; for example, it is stretchable, waterproof, and chemical- and abrasion-resistant. The wide application of neoprene has resulted in numerous case reports of dermatitis patients allergic to DPTU. The mechanism by which DPTU works as a contact allergen has not been described; thus, the aim of the present study was to investigate if DPTU is a prohapten that can be activated by skin metabolism. The metabolic activation and covalent binding of 14C-labeled DPTU to proteins were tested using a skinlike cytochrome P450 (P450) cocktail containing the five most abundant P450s found in human skin (CYP1A1, 1B1, 2B6, 2E1, and 3A5) and human liver microsomes. The incubations were carried out in the presence or absence of the metabolite trapping agents glutathione, methoxylamine, and benzylamine. The metabolism mixtures were analyzed by LC-radiochromatography, LC-MS, and LC-MS/MS. DPTU was mainly metabolically activated to reactive sulfoxides resulting in desulfurated adducts in both enzymatic systems used. Also, phenylisothiocyanate and phenylisocyanate were found to be metabolites of DPTU.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.